scholarly article | Q13442814 |
P356 | DOI | 10.3390/V8090254 |
P8608 | Fatcat ID | release_laukbugvlfg2dmyzjtnvr4lmem |
P932 | PMC publication ID | 5035968 |
P698 | PubMed publication ID | 27649230 |
P50 | author | Karl-Klaus Conzelmann | Q30002171 |
Gert Zimmer | Q38804568 | ||
P2093 | author name string | Samira Locher | |
Sarah Moeschler | |||
Beate Krämer | |||
P2860 | cites work | Correction: Estimating the global burden of endemic canine rabies | Q21144474 |
Fatal human infection with rabies-related Duvenhage virus, South Africa | Q24628684 | ||
Taxonomy of the order Mononegavirales: update 2016 | Q28275807 | ||
Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species | Q30875451 | ||
A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon | Q31037459 | ||
A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein | Q31150358 | ||
The rhabdoviruses: biodiversity, phylogenetics, and evolution | Q33449999 | ||
Rabies-specific antibodies: measuring surrogates of protection against a fatal disease | Q33541002 | ||
Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use | Q82817379 | ||
The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines | Q83269151 | ||
Generation of recombinant rabies Virus CVS-11 expressing eGFP applied to the rapid virus neutralization test | Q33584768 | ||
Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity | Q33838289 | ||
A Fatal Human Infection with Mokola Virus * | Q34215531 | ||
Rabies virus glycoprotein. II. Biological and serological characterization | Q34408674 | ||
Rabies re-examined | Q34764816 | ||
A recombinant rabies virus expressing a phosphoprotein-eGFP fusion is rescued and applied to the rapid virus neutralization antibody assay | Q35595566 | ||
Development and Applications of VSV Vectors Based on Cell Tropism | Q35679152 | ||
Re-evaluating the burden of rabies in Africa and Asia. | Q36174024 | ||
Genomic diversity and evolution of the lyssaviruses | Q36575472 | ||
A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa | Q37461555 | ||
Human rabies due to lyssavirus infection of bat origin | Q37699593 | ||
Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine? | Q38053739 | ||
Australian Bat Lyssavirus in a child: the first reported case | Q38192973 | ||
Current status of rabies and prospects for elimination | Q38211810 | ||
G gene-deficient single-round rabies viruses for neuronal circuit analysis | Q38525112 | ||
Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesis | Q39328640 | ||
Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. | Q39869015 | ||
A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). | Q39897024 | ||
Concepts in the pathogenesis of rabies | Q39965361 | ||
A rapid reproducible test for determining rabies neutralizing antibody | Q40870187 | ||
Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. | Q41739249 | ||
Monte Carlo simulation of the Spearman-Kaerber TCID50. | Q42536190 | ||
Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein | Q42604413 | ||
Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region | Q42615215 | ||
Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions | Q42657452 | ||
Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies | Q44937479 | ||
Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity | Q45374488 | ||
Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes | Q45481602 | ||
Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody | Q45754757 | ||
Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis | Q48218249 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P921 | main subject | vesicular stomatitis | Q11549084 |
P577 | publication date | 2016-09-16 | |
P1433 | published in | Viruses | Q7935305 |
P1476 | title | Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles | |
P478 | volume | 8 |
Q54976877 | 1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features. |
Q60955902 | A high throughput neutralization test based on GFP expression by recombinant rabies virus |
Q47568014 | Current status on the development of pseudoviruses for enveloped viruses |
Q59792289 | Establishment of a Chinese street rabies virus library and its application for detecting neutralizing activity |
Q41927480 | Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein |
Q64360174 | Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting |
Q99728288 | Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay |
Q39393526 | Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review |
Search more.